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showedmodified rotational thromboe-
lastometry and multiple electrode ag-
gregometry results as predictors of
excessive bleeding after cardiac surgi-
cal procedures. Preoperative platelet
function assessment and intraopera-
tive hemostatic property optimization
guided by thromboelastometry can
reduce the tendency toward excessive
bleeding, leading to diminished use of
rFVIIa with even better efficiency
after functional hemostatic properties
optimization before rFVIIa adminis-
tration. It is noteworthy that concomi-
tant use of multiple-electrode
aggregometry and modified rotational
thromboelastometry can help to
discriminate excessive bleeding as
a surgical or a coagulopathic bleeding.
Any rFVIIa administration should
follow previously mentioned preoper-
ative and intraoperative hemostatic
optimization measures determined
from suitable bedside hemostatic
monitoring devices with a short time
frame from blood sampling to getting
results. In our experience, such an
algorithm can help in reducing both
chest tube output and blood product
transfusion requirements, with
onlysporadic need for rFVIIa
administration.
We congratulate Goksedef and col-
leagues1 on their elegant and timely
research.
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j.jtcvs.2012.06.062PERVENTRICULAR CLOSURE
OF POSTINFARCT SEPTAL
RUPTURE REVISITED
To the Editor:
We readwith great interest and sense
of nostalgia the brief report on the tech-
nique of perventricular device closure
in post–myocardial infarction septal
defect by Love and colleagues1 in
2011. They reported 2 cases of cardio-
genic shock aftermyocardial infarction
with septal defects sized 25 and 28mm.
They used the Amplatzer septal oc-
cluder (St Jude Medical, Inc, St Paul,
Minn) sized 34 mm through a 12F
and13-cmCook (CookGroup Incorpo-
rated, Bloomington, Ind) sheath ad-
vanced over a guide wire. The large
50-mm left disk of the Amplatzer de-
vice was placed flush with the septum
anddelivered in the left ventricular cav-
ity. Then, with traction on the delivery
system and countertraction on the right
ventricular free wall, the proximal disk
was deployed exteriorly on the right
ventricular surface. After detachment
of the device from the delivery system,
they went on to tie the purse-string
suture and sutured a piece of bovine
pericardium between the right ventric-
ular free wall and the device to prevent
device erosion caused by movement.
Both patients had an uneventful recov-
ery despite a small residual ventricular
septal defect, and early discharge
from the hospital compared with con-
ventional open techniques of repairof Thoracic and Cardiovascular Surger(though one of them needed an addi-
tional ventricular septal defect muscu-
lar occluder inserted transfemorally
on the 10thpostoperative day).Of these
2 patients, 1 continued to do well 13
months postoperatively; however, after
3 weeks the other returned in a state of
profound low cardiac output and died
despite a minimal residual ventricular
septal defect, primarily because of
biventricular myocardial failure.
Although Love and colleagues1
noted that they were unaware of any
previous such reports in the indexed
literature,wewould like to take this op-
portunity to bring readers’ attention to
our previous presentation, the world’s
first case report video with this hybrid
technique in 2006.The techniquevideo
with 13-month follow up was pre-
sented in the teaching video sessions
of the 2008 annual conference of the
International Society of Minimally
Invasive Cardiothoracic Surgery meet-
ing in Boston . The abstract was pub-
lished in the Society’s official journal
Innovations.2
This 62-year-old male, hyperten-
sive, nondiabetic patient presented in
cardiogenic shock as a result of infe-
rior wall myocardial infarction, which
also involved the right ventricle, and
anuria. The patient was initially man-
aged with an intra-aortic balloon
pump for 9 days. As urine started
flowing and renal function improved,
coronary arteriography revealed criti-
cal triple vessel disease with a left
ventricular ejection fraction of 30%
and a right ventricular ejection frac-
tion of 25%. The patient had a septal
aneurysm on the right ventricular
side, with multiple sievelike septal ne-
croses (type III dissecting septal rup-
ture) measuring 18 mm. In view of
the prohibitive risk of conventional
open surgery in this situation, we
(like Love and colleagues1) involved
a pediatric cardiologist and decided
to use transesophageal echocardiogra-
phy for hybrid imaging and off-pump
triple bypass. This included a left in-
ternal thoracic artery graft to the left
anterior descending coronary arteryy c Volume 144, Number 6 1535
Letters to the Editorand reversed saphenous vein grafts to
the right and circumflex coronary ar-
teries. The right, left anterior descend-
ing, and left circumflex coronary
arteries were grafted in that order
with proximal first technique for the
reversed saphenous vein grafts. This
actually led to immediate improve-
ment of the right ventricular ejection
fraction, as confirmed on echocardi-
ography. Then with the finger-dip
technique we passed a 16-gauge
needle through a pledgeted purse-
string 4-0 polypropylene (Prolene) su-
ture on the right ventricular anterior
wall to insert a guide wire across the
septal tear into the left ventricle. The
20-mm Amplatzer septal occluder
device was then deployed through
a 9F vascular sheath entirely into the
necrotic cavity in the septum. The de-
vice deployment did not appear satis-
factory initially because of the nature
of the large septal necrotic cavity. It
soon became clear, however, that the
device had entrenched itself nicely,
was well trapped in the septal aneu-
rysm, and had nearly completely
obliterated the large 3:1 shunt. In
2008, we had a 13-month follow-up
with stable device intracardiac and
septal position with New York Heart
Association class I functional status.
Unlike Love and colleagues,1 we
deployed the device totally intracar-
diac and were able to discharge the
patient on the 9th postoperative day.
The patient exhibited no evidence of
subsequent myocardial failure and
continued to show improved contrac-
tile function despite a continued small
residual ventricular septal defect. We
believe that placing a large disk on
the exterior anterior right ventricular
surface may contribute to late myocar-
dial failure because of fibrosis on a de-
vice primarily meant for intravascular
placement. This kind of technique
would also be limited in application
if a right ventricular infarction is
present, as in our case, because of
the risk of erosion into the infarcted
myocardium.1536 The Journal of Thoracic andHarshbir Singh Pannu,
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MITRAL PROSTHESIS WITHIN
ALL KINDS OF MITRAL RINGS
THROUGH ATRANSAPICAL
APPROACH?
To the Editor:
We appreciate the admirable efforts
of Holzhey and colleagues1 to treat
a patient who had double valve dis-
ease and coronary heart disease with
poor left ventricular function. The pa-
tient had undergone mitral valve re-
construction and coronary artery
bypass grafting 12 years previously
and was in New York Heart Associa-
tion functional class IV. The echocar-
diographic examination revealed
structural degeneration of the repaired
mitral valve, with moderate to severe
mitral stenosis and grade II insuffi-
ciency. Further echocardiographic
findings included severely stenosed
aortic valve disease and moderate tri-
cuspid insufficiency. Moreover, 2 de
novo lesions of the proximal right
coronary artery were detected by
coronary angiography. SummarizingCardiovascular Surgery c December 20briefly, it was a complex case for inter-
vention. Nonetheless the patient was
treated successfully.
Anson and associates2 performed
transcatheter mitral valve-in-valve
implantation in circular-shaped pros-
thesis in 11 patients. They concluded
that proper anchoring of the balloon-
expandable valve within the sewing
ring of the mitral prosthesis ensured
stability and minimized paravalvular
leakage. We think that some points
about the procedure performed in the
mitral position have to be clarified to
avoid misunderstanding.
First, what kind of ring had been
implanted in previous surgery: rigid,
semirigid, or flexible? We know that
some of the flexible rings, which are
easily deformable, have polyester
cores. The Carpentier-Edwards clas-
sic ring (Edwards Lifesciences Corp,
Irvine, Calif), which is hardly deform-
able, has a titanium core, and
Carpentier-McCarthy-Adams IMR
ETlogix ring (Edwards Lifesciences),
which is nondeformable, also has
a rigid titanium core.3 The structures
of the rings are important even if the
patient hasn’t undergone coronary ar-
tery bypass grafting. If the ring has
rigid structure such as a titanium
core, balloon valvuloplasty or balloon
inflation to expand the valved prosthe-
sis may not result in circular mitral
ring. This may lead to paracommisu-
ral leaks between the prosthesis and
the ring. Holzhey and colleagues1
claim that there were 2 trivial jets be-
tween the prosthesis and the ring. Was
the previously implanted ring flexi-
ble? Another point to be clarified is
the balloon pressure during balloon
valvuloplasty or expansion of a valved
prosthesis in the mitral position. In
such cases, how much is the pressure
that we can apply to make the ring in
circular shape?
In conclusion, this is an appreciable
study. We as readers thank Holzhey
and colleagues1 for sharing their
knowledge and experience about
such a complicated case.12
